BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 794465)

  • 1. Androgen receptors and the molecular basis for the action of antiadrogens in the ventral prostate.
    Tymoczko JL; Liao S
    J Reprod Fertil Suppl; 1976 Sep; (24 suppl):147-62. PubMed ID: 794465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.
    Ghanadian R; Smith CB; Williams G; Chisholm GD
    Br J Urol; 1977; 49(7):695-700. PubMed ID: 74269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the nuclear dihydrotestosterone receptor complex from rat ventral prostate by antiandrogens and stilboestrol.
    Smith CB; Ghanadian R; Chisholm GD
    Mol Cell Endocrinol; 1978; 10(1):13-20. PubMed ID: 75813
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen receptors in benign and malignant prostatic tissue.
    Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
    Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of action of androgens and antiandrogens: effects of antiandrogens on translocation of cytoplasmic androgen receptor and nuclear abundance of dihydrotestosterone.
    Callaway TW; Bruchovsky N; Rennie PS; Comeau T
    Prostate; 1982; 3(6):599-610. PubMed ID: 7155992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiandrogens on the binding of androgen to cytosol and nuclei of hamster sebaceous glands.
    Takayasu S
    Arch Dermatol Res; 1979 Feb; 264(1):49-54. PubMed ID: 443861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha-related apoptosis-inducing ligand decoy receptor DcR2 is targeted by androgen action in the rat ventral prostate.
    Vindrieux D; Réveiller M; Florin A; Blanchard C; Ruffion A; Devonec M; Benahmed M; Grataroli R
    J Cell Physiol; 2006 Mar; 206(3):709-17. PubMed ID: 16245307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of androgens and antiandrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Res; 1976 Dec; 36(12):4610-8. PubMed ID: 1000506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
    Fenton MA; Shuster TD; Fertig AM; Taplin ME; Kolvenbag G; Bubley GJ; Balk SP
    Clin Cancer Res; 1997 Aug; 3(8):1383-8. PubMed ID: 9815822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of intracellular regulation of protein kinase CK2: role of stimulus-mediated subnuclear association.
    Ahmed K; Tawfic S
    Cell Mol Biol Res; 1994; 40(5-6):539-45. PubMed ID: 7735328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
    Wilson MJ; Ludowese C; Sinha AA; Estensen RD
    Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of androgen-receptor interaction in mouse prostate gland cytosol by divalent metal ions.
    Donovan MP; Schein LG; Thomas JA
    Mol Pharmacol; 1980 Mar; 17(2):156-62. PubMed ID: 7393202
    [No Abstract]   [Full Text] [Related]  

  • 15. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 16. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity.
    Wang LG; Liu XM; Kreis W; Budman DR
    Biochem Biophys Res Commun; 1999 May; 259(1):21-8. PubMed ID: 10334909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.
    Steinsapir J; Mora G; Muldoon TG
    Biochim Biophys Acta; 1991 Aug; 1094(1):103-12. PubMed ID: 1883848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with antiandrogens induces an androgen-repressed gene in the rat ventral prostate.
    Léger JG; Le Guellec R; Tenniswood MP
    Prostate; 1988; 13(2):131-42. PubMed ID: 2459682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of prolactin in regressing prostate: independent of action mediated by androgen receptors.
    Assimos D; Smith C; Lee C; Grayhack JT
    Prostate; 1984; 5(6):589-95. PubMed ID: 6494057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens.
    Brown TR; Rothwell SW; Sultan C; Migeon CJ
    Steroids; 1981 Jun; 37(6):635-48. PubMed ID: 6457421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.